Cryptococcosis Market: By Treatment (Amphotericin B, Flucytosine, Fluconazole, Voriconazole, Surgery Treatment, Others), Diagnosis (Cryptococcal antigen, Bronchoscopy, X-ray, MRI, Lung Biopsy, CSF Polymerase Chain Reaction, Lumber Puncture, Urine Test, CT scan, Others), By End-Users (Clinic, Hospital, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Cryptococcosis Market size was valued at USD 5,273.5 million in 2022 and is poised to grow at a CAGR of 4.5% from 2023-2029. Cryptococcosis is a fungal infection caused by Cryptococcus species, mainly Cryptococcus neoformans and Cryptococcus gattii, and primarily affects the lungs, it can also spread to other bodily regions, including the central nervous system (CNS), which can result in infections that are more severe. According to WHO, Cryptococcal meningitis is responsible for an estimated 15% of all HIV-related deaths globally – 3 quarters of which occur in sub-Saharan Africa. It is estimated that 223,100 cases of cryptococcal meningitis result in 181,000 deaths each year among PLHIV. An increase in the population of people suffering from HIV and AIDS who are extremely vulnerable to many forms of diseases, including infections with cryptococcosis drives the cryptococcosis market. Moreover, the development of more accurate and rapid diagnostic tests for Cryptococcosis for earlier detection and treatment, improving patient outcomes has provided developmental opportunities for research institutes and pharmaceutical companies. Additionally, the market is experiencing profitable expansion potential by virtue of supportive government initiatives for the creation of efficient medications for the treatment of cryptococcal meningitis. For instance, the South African government implemented a South African National Strategic Plan for HIV, STIs, and TB that also complements early detection of cryptococcal disease at PHC clinics rather than delayed diagnosis of cryptococcal meningitis at the hospital level. But rapid diagnostic tests and lumbar puncture are frequently not available, which results in patients not being diagnosed at an early enough stage. The first-line antifungal medications that are used to treat cryptococcal meningitis are pricy and frequently unavailable to save the lives of those who are sick and further hinder the growth of the market. However, the growing prevalence of infectious diseases, greater understanding of the diagnosis increases in government funding, rising healthcare costs and increased adoption of state-of-art diagnostic equipment in healthcare organizations are witnessed to boost the market.

Cryptococcosis Market Key Developments:
  • In June 2022, Glenmark Pharmaceuticals. Ltd., announced the acquisition of the approved generic versions of certain over-the-counter drugs from Wockhardt Ltd in the United States. The acquisition by the company's fully-owned subsidiary Glenmark Pharmaceuticals. Inc., USA includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg and 20 mg used to treat and prevent ulcers in the stomach and intestine.
  • In February 2019, The Food and Drug Administration (FDA) granted Orphan Drug designation to APX001 (Amplyx Pharmaceuticals) for the treatment of cryptococcosis. APX001 is a broad-spectrum antifungal that works by inhibiting the fungal enzyme Gwt1.

Cryptococcosis Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.50%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Cryptococcosis Market Dynamics

The market is expected to grow at significant growth rate due to the increased number of drugs approvals for cryptococcosis. The choice of antifungal treatment and the duration of therapy may vary depending on the severity of the infection but the primary drug of choice for the treatment of cryptococcosis is amphotericin B. Amphotericin B is a potent antifungal drug that works by attaching to the fungal cell membrane, causing the creation of holes that compromise the integrity of the cell membrane and result in cell death in Cryptococcus species. Particularly when the illness affects the central nervous system (cryptococcal meningitis), it is regarded as a first-line treatment for severe or life-threatening cryptococcal infections. Recently, in October 2019, the Food and Drug Administration (FDA) granted Orphan Drug designation to MAT2203 (Matinas BioPharma) for the treatment of cryptococcosis.

Cryptococcosis Market Segmentation

By Treatment
  • Amphotericin B
  • Flucytosine
  • Fluconazole
  • Voriconazole
  • Surgery Treatment
  • Others
By Diagnosis
  • Cryptococcal antigen
  • Bronchoscopy
  • X-ray
  • MRI
  • Lung Biopsy
  • CSF Polymerase Chain Reaction
  • Lumber Puncture
  • Urine Test
  • CT scan
  • Others
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
By End User
  • Clinic
  • Hospital
  • Others

Frequently Asked Questions

The cryptococcosis market valued at USD 5,273.5 Million in 2022

The development of more accurate and rapid diagnostic tests for Cryptococcosis for earlier detection and treatment, improving patient outcomes has provided developmental opportunities for research institutes and pharmaceutical companies.

The cryptococcosis market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2. Global Cryptococcosis Market Introduction 
2.1.Global Cryptococcosis Market  - Taxonomy
2.2.Global Cryptococcosis Market  - Definitions
2.2.1.Treatment
2.2.2.Diagnosis
2.2.3. Distribution Channel
2.2.4.End User
2.2.5.Region
3. Global Cryptococcosis Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Cryptococcosis Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Cryptococcosis Market  By Treatment, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Amphotericin B
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Flucytosine
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Fluconazole
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Voriconazole
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Surgery Treatment
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6. Global Cryptococcosis Market  By Diagnosis, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Cryptococcal antigen
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Bronchoscopy
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. X-ray
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. MRI
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Lung Biopsy
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. CSF Polymerase Chain Reaction
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Lumber Puncture
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Urine Test
6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
6.9. CT scan
6.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.9.3. Market Opportunity Analysis 
6.10. Others
6.10.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.10.3. Market Opportunity Analysis 
7. Global Cryptococcosis Market  By  Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospital Pharmacy
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacy
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacy
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Cryptococcosis Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Clinic
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Hospital
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Others
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9. Global Cryptococcosis Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Cryptococcosis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Amphotericin B
10.1.2.Flucytosine
10.1.3.Fluconazole
10.1.4.Voriconazole
10.1.5.Surgery Treatment
10.1.6.Others
10.2.  Diagnosis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cryptococcal antigen
10.2.2.Bronchoscopy
10.2.3.X-ray
10.2.4.MRI
10.2.5.Lung Biopsy
10.2.6.CSF Polymerase Chain Reaction
10.2.7.Lumber Puncture
10.2.8.Urine Test
10.2.9.CT scan
10.2.10.Others
10.3.   Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacy
10.3.2.Retail Pharmacy
10.3.3.Online Pharmacy
10.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Clinic
10.4.2.Hospital
10.4.3.Others
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Cryptococcosis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Amphotericin B
11.1.2.Flucytosine
11.1.3.Fluconazole
11.1.4.Voriconazole
11.1.5.Surgery Treatment
11.1.6.Others
11.2.  Diagnosis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cryptococcal antigen
11.2.2.Bronchoscopy
11.2.3.X-ray
11.2.4.MRI
11.2.5.Lung Biopsy
11.2.6.CSF Polymerase Chain Reaction
11.2.7.Lumber Puncture
11.2.8.Urine Test
11.2.9.CT scan
11.2.10.Others
11.3.   Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacy
11.3.2.Retail Pharmacy
11.3.3.Online Pharmacy
11.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Clinic
11.4.2.Hospital
11.4.3.Others
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Cryptococcosis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Amphotericin B
12.1.2.Flucytosine
12.1.3.Fluconazole
12.1.4.Voriconazole
12.1.5.Surgery Treatment
12.1.6.Others
12.2.  Diagnosis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cryptococcal antigen
12.2.2.Bronchoscopy
12.2.3.X-ray
12.2.4.MRI
12.2.5.Lung Biopsy
12.2.6.CSF Polymerase Chain Reaction
12.2.7.Lumber Puncture
12.2.8.Urine Test
12.2.9.CT scan
12.2.10.Others
12.3.   Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacy
12.3.2.Retail Pharmacy
12.3.3.Online Pharmacy
12.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Clinic
12.4.2.Hospital
12.4.3.Others
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Cryptococcosis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Amphotericin B
13.1.2.Flucytosine
13.1.3.Fluconazole
13.1.4.Voriconazole
13.1.5.Surgery Treatment
13.1.6.Others
13.2.  Diagnosis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cryptococcal antigen
13.2.2.Bronchoscopy
13.2.3.X-ray
13.2.4.MRI
13.2.5.Lung Biopsy
13.2.6.CSF Polymerase Chain Reaction
13.2.7.Lumber Puncture
13.2.8.Urine Test
13.2.9.CT scan
13.2.10.Others
13.3.   Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacy
13.3.2.Retail Pharmacy
13.3.3.Online Pharmacy
13.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Clinic
13.4.2.Hospital
13.4.3.Others
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Cryptococcosis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Amphotericin B
14.1.2.Flucytosine
14.1.3.Fluconazole
14.1.4.Voriconazole
14.1.5.Surgery Treatment
14.1.6.Others
14.2.  Diagnosis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Cryptococcal antigen
14.2.2.Bronchoscopy
14.2.3.X-ray
14.2.4.MRI
14.2.5.Lung Biopsy
14.2.6.CSF Polymerase Chain Reaction
14.2.7.Lumber Puncture
14.2.8.Urine Test
14.2.9.CT scan
14.2.10.Others
14.3.   Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Hospital Pharmacy
14.3.2.Retail Pharmacy
14.3.3.Online Pharmacy
14.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Clinic
14.4.2.Hospital
14.4.3.Others
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Bristol-Myers Squibb Company
15.2.2.Pfizer Inc
15.2.3.Astellas Pharma Inc.
15.2.4.Sigmapharm Laboratories LLC
15.2.5.Glenmark Pharmaceuticals
15.2.6.Janssen Biotech Inc. (Johnson & Johnson)
15.2.7.Abbott Laboratories
15.2.8.Novartis AG
15.2.9.Valeant Pharmaceuticals Inc.
15.2.10.Lupin Ltd
15.2.11.Amplyx Pharmaceuticals
15.2.12.Abbott Laboratories
15.2.13.Teva Pharmaceutical Industries Ltd.
16. Research Methodology 
17. Appendix and Abbreviations 
  • Bristol-Myers Squibb Company
  • Pfizer Inc
  • Astellas Pharma Inc.
  • Sigmapharm Laboratories LLC
  • Glenmark Pharmaceuticals
  • Janssen Biotech Inc. (Johnson & Johnson)
  • Abbott Laboratories
  • Novartis AG
  • Valeant Pharmaceuticals Inc.
  • Lupin Ltd
  • Amplyx Pharmaceuticals
  • Abbott Laboratories
  • Teva Pharmaceutical Industries Ltd.

Adjacent Markets